Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

25.30
Delayed Data
As of Feb 17
 0.00 / 0.00%
Today’s Change
16.40
Today|||52-Week Range
37.36
+34.57%
Year-to-Date
Acorda (ACOR) Reports Narrower-than-Expected Loss in Q4
Feb 15 / Zacks.com - Paid Partner Content
Agios Pharmaceuticals (AGIO) Q4 Earnings: What's in Store?
Feb 10 / Zacks.com - Paid Partner Content
Analysts' Actions -- Acorda, Restoration Hardware, Humana, Merck and More
Feb 15 / TheStreet.com - Paid Partner Content
Perrigo Company (PRGO) Q4 Earnings: Disappointment in Store?
Feb 10 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Present...
Feb 15 / Zacks.com - Paid Partner Content
Acorda (ACOR) Catches Eye: Stock Gains 20.8% in Session
Feb 10 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Incyte, Prothena, Acorda Therapeutics and Axovant ...
Feb 14 / Zacks.com - Paid Partner Content
Why Acorda Therapeutics Stock Is Jumping Today
Feb 09 / MotleyFool.com - Paid Partner Content
Drug Stocks Earnings Slated for Feb 14: INCY, PRTA & More
Feb 13 / Zacks.com - Paid Partner Content
Can Prothena (PRTA) Pull a Surprise This Earnings Season?
Feb 08 / Zacks.com - Paid Partner Content
Alexion (ALXN) Q4 Earnings: Can the Stock Pull a Surprise?
Feb 10 / Zacks.com - Paid Partner Content
Teva (TEVA) Q4 Earnings: What's in Store for the Stock?
Feb 08 / Zacks.com - Paid Partner Content